Inge G P Geelen

5PUBLICATIONS
6CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCellular immunologyHaematological tumoursCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 17, 2025
Treatment-Free Remission Outcomes in a BCR::ABL1 Digital PCR Selected Clinical Cohort of CML Patients.

C Kockerols, P J M Valk, P Hogenbirk

|Apr 29, 2023
Switching from imatinib to nilotinib plus pegylated interferon-α2b in chronic phase CML failing to achieve deep molecular response: clinical and immunological effects.

Inge G P Geelen, Stein-Erik Gullaksen, Mette M Ilander

|Jul 12, 2020
Blood cell counts and lymphocyte subsets of patients admitted during the COVID-19 pandemic: a prospective cohort study.

Paul J Hengeveld, Aaram O Khader, Linda H A de Bruin

|Dec 31, 2017
Omitting cytogenetic assessment from routine treatment response monitoring in chronic myeloid leukemia is safe.

Inge G P Geelen, Noortje Thielen, Jeroen J W M Janssen

|Jul 19, 2017
Influence of WHO versus ELN advanced phase chronic myeloid leukemia definitions on overall survival.

Inge G P Geelen, Noortje Thielen, Jeroen J W M Janssen

Pageof 1

Frequent Collaborators

2 joint publications

Peter E Westerweel

1 joint publications

C Kockerols

1 joint publications

Paul J Hengeveld

1 joint publications

Nathalie I Bouwer